Maitreyee Bhattacharyya
Overview
Explore the profile of Maitreyee Bhattacharyya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghosh M, Shaw J, Dasgupta A, Bhattacharyya M
Indian J Med Res
. 2024 Nov;
160(2):210-216.
PMID: 39513208
Background & objectives Subclinical joint bleed is a matter of concern in individuals with hemophilia on prophylaxis. Ultrasonography (USG) is mostly used for the screening of subclinical bleeds in such...
2.
Bhattacharjee S, Ghosh S, Shaw J, Bhattacharjee S, Bhattacharyya M
Hemoglobin
. 2024 Aug;
48(3):161-168.
PMID: 39092801
Transfusion-dependent thalassemia (TDT) is a major public health concern in India, requiring regular transfusions for survival. There is also significant morbidity caused by iron overload and transfusion related infections. Novel...
3.
Pramanik P, Ghosh M, Mitra S, Bandopadhyay B, Bhattacharyya M
Indian J Hematol Blood Transfus
. 2024 Jul;
40(3):538-539.
PMID: 39011259
No abstract available.
4.
Jha K, Saha S, Bhattacharyya M
South Asian J Cancer
. 2024 Jun;
13(2):126-131.
PMID: 38919660
Karuna Jha Multiple myeloma is a cytogenetically heterogeneous, evolving, and incurable disease. Differences in prevalence of myeloma already exist in Indian subcontinent as compared with Western world countries. This study...
5.
Shaw J, Patra A, Khatun A, Ray R, Ghosh A, Mahapatra S, et al.
EJHaem
. 2024 Jun;
5(3):440-446.
PMID: 38895064
The phenotype of β-thalassemia varies widely. The primary determinant is the type of beta-globin gene mutation; however, there are secondary and tertiary modifiers also as associated alpha mutations, polymorphisms, as...
6.
Kar R, Anand J, Kar S, Banu N, Kuppusamy D, Sivanantham P, et al.
J Family Med Prim Care
. 2023 Sep;
12(8):1629-1635.
PMID: 37767435
Background: Haemoglobin disorders are unique and important health challenges for tribal populations. Hence, this study was undertaken with the aim to screen for haematological disorders, particularly anaemia and haemoglobinopathies, and...
7.
Bhattacharjee S, Ghosh S, Bhattacharyya M
Indian J Hematol Blood Transfus
. 2023 Jun;
39(3):487-490.
PMID: 37304483
Purpose: Chemo-immunotherapies like Fludarabine-Cyclophosphamide-Rituximab (FCR) are used for treatment of chronic lymphocytic leukemia (CLL) in young and fit patients while Bendamustine-Rituximab (BR) is used in older patients. In a resource...
8.
Shaw J, Ray R, Bhattacharjee S, Dasgupta A, Bhattacharyya M
Indian J Public Health
. 2023 Apr;
67(1):159-161.
PMID: 37039223
Hemoglobinopathy is a major concern among the tribal population which constitutes 8.6% of the total population, and West Bengal (WB) is the home to 5.3 million tribes. The present study...
9.
Bhattacharjee S, Ghosh S, Bhattacharyya M
Indian J Cancer
. 2023 Mar;
59(4):560-564.
PMID: 36861523
Synchronous malignancies involving acute leukemia and a solid organ are rare. Bleeding per rectum is a common manifestation of acute leukemia during induction chemotherapy and might mask the presence of...
10.